Management of anaemia in chronic kidney disease: summary of updated NICE guidance
About 5% of the population of the United States and United Kingdom have stages 3-5 chronic kidney disease (CKD; estimated glomerular filtration rate (eGFR)
Gespeichert in:
| Veröffentlicht in: | BMJ (Online) 2015-06, Vol.350 (jun04 6), p.h2258-h2258 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | h2258 |
|---|---|
| container_issue | jun04 6 |
| container_start_page | h2258 |
| container_title | BMJ (Online) |
| container_volume | 350 |
| creator | Padhi, Smita Glen, Jessica Pordes, Ben A J Thomas, Mark E |
| description | About 5% of the population of the United States and United Kingdom have stages 3-5 chronic kidney disease (CKD; estimated glomerular filtration rate (eGFR) |
| doi_str_mv | 10.1136/bmj.h2258 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1702644443</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26520870</jstor_id><sourcerecordid>26520870</sourcerecordid><originalsourceid>FETCH-LOGICAL-b312t-ac776b08b0ecc28378abe0e6dcb673b53c1c5a55ae74812bfe16a7862f1e76d63</originalsourceid><addsrcrecordid>eNqFkUtLxDAUhYMozqAu_AFKQBe6qObRPOpOBl_gA0HXJUlvndZpOzbtYv69qVURQTybEM7Hyb05CO1SckIpl6e2Kk_mjAm9hqZUCRlRzfk6mpJEJJGmXE_QjvclIYRxpRMpNtGESRLHlLMperwztXmBCuoONzkOF6gKg4sau3nb1IXDr0VWwwpnhQfj4Qz7vqpMuxrofpmZDjJ8fzO7wC99kZnawTbayM3Cw87nuYWeLy-eZtfR7cPVzez8NrKcsi4yTilpibYEnGM6jGYsEJCZs1JxK7ijThghDKhYU2ZzoNIoLVlOQclM8i10NOYu2-atB9-lVeEdLBamhqb3KVWEyTiI_49KLZNEs4QF9OAXWjZ9W4dFQmCQJIrGgToeKdc23reQp8u2GH4lpSQdWklDK-lHK4Hd_0zsbQXZN_nVQQD2RqD0XdP-8AUjWpHgH47-kPn3O-8xapsz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777760714</pqid></control><display><type>article</type><title>Management of anaemia in chronic kidney disease: summary of updated NICE guidance</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><creator>Padhi, Smita ; Glen, Jessica ; Pordes, Ben A J ; Thomas, Mark E</creator><creatorcontrib>Padhi, Smita ; Glen, Jessica ; Pordes, Ben A J ; Thomas, Mark E ; Guideline Development Group ; on behalf of the Guideline Development Group</creatorcontrib><description>About 5% of the population of the United States and United Kingdom have stages 3-5 chronic kidney disease (CKD; estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2),1 2 and about 15% of these people have anaemia according to World Health Organization criteria.2 Overall more than 100?000 people in the UK have anaemia of CKD.3 Anaemia of CKD develops as renal disease progresses, and it is mainly caused by erythropoietin deficiency; other contributory factors include deficiency of iron, folate, or vitamin B12; blood loss; and infection or inflammation. This article summarises 2006 and 2011 guidance from the National Institute for Health and Care Excellence (NICE) on the management of anaemia of CKD,3 4 and it also highlights key points of the 2015 update.5</description><identifier>ISSN: 0959-8138</identifier><identifier>ISSN: 1756-1833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.h2258</identifier><identifier>PMID: 26044132</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Anemia ; Anemia - complications ; Anemia - diagnosis ; Anemia - therapy ; Blood diseases ; Cohort analysis ; Cost analysis ; GUIDELINES ; Hemodialysis ; Hemoglobin ; Humans ; Investigations ; Iron ; Kidney diseases ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - diagnosis ; Renal Insufficiency, Chronic - therapy</subject><ispartof>BMJ (Online), 2015-06, Vol.350 (jun04 6), p.h2258-h2258</ispartof><rights>BMJ Publishing Group Ltd 2015</rights><rights>Copyright BMJ Publishing Group LTD Jun 4, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b312t-ac776b08b0ecc28378abe0e6dcb673b53c1c5a55ae74812bfe16a7862f1e76d63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/350/bmj.h2258.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/350/bmj.h2258.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,799,3183,23550,27901,27902,57992,58225,77342,77373</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26044132$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Padhi, Smita</creatorcontrib><creatorcontrib>Glen, Jessica</creatorcontrib><creatorcontrib>Pordes, Ben A J</creatorcontrib><creatorcontrib>Thomas, Mark E</creatorcontrib><creatorcontrib>Guideline Development Group</creatorcontrib><creatorcontrib>on behalf of the Guideline Development Group</creatorcontrib><title>Management of anaemia in chronic kidney disease: summary of updated NICE guidance</title><title>BMJ (Online)</title><addtitle>BMJ</addtitle><description>About 5% of the population of the United States and United Kingdom have stages 3-5 chronic kidney disease (CKD; estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2),1 2 and about 15% of these people have anaemia according to World Health Organization criteria.2 Overall more than 100?000 people in the UK have anaemia of CKD.3 Anaemia of CKD develops as renal disease progresses, and it is mainly caused by erythropoietin deficiency; other contributory factors include deficiency of iron, folate, or vitamin B12; blood loss; and infection or inflammation. This article summarises 2006 and 2011 guidance from the National Institute for Health and Care Excellence (NICE) on the management of anaemia of CKD,3 4 and it also highlights key points of the 2015 update.5</description><subject>Anemia</subject><subject>Anemia - complications</subject><subject>Anemia - diagnosis</subject><subject>Anemia - therapy</subject><subject>Blood diseases</subject><subject>Cohort analysis</subject><subject>Cost analysis</subject><subject>GUIDELINES</subject><subject>Hemodialysis</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Investigations</subject><subject>Iron</subject><subject>Kidney diseases</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - diagnosis</subject><subject>Renal Insufficiency, Chronic - therapy</subject><issn>0959-8138</issn><issn>1756-1833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUtLxDAUhYMozqAu_AFKQBe6qObRPOpOBl_gA0HXJUlvndZpOzbtYv69qVURQTybEM7Hyb05CO1SckIpl6e2Kk_mjAm9hqZUCRlRzfk6mpJEJJGmXE_QjvclIYRxpRMpNtGESRLHlLMperwztXmBCuoONzkOF6gKg4sau3nb1IXDr0VWwwpnhQfj4Qz7vqpMuxrofpmZDjJ8fzO7wC99kZnawTbayM3Cw87nuYWeLy-eZtfR7cPVzez8NrKcsi4yTilpibYEnGM6jGYsEJCZs1JxK7ijThghDKhYU2ZzoNIoLVlOQclM8i10NOYu2-atB9-lVeEdLBamhqb3KVWEyTiI_49KLZNEs4QF9OAXWjZ9W4dFQmCQJIrGgToeKdc23reQp8u2GH4lpSQdWklDK-lHK4Hd_0zsbQXZN_nVQQD2RqD0XdP-8AUjWpHgH47-kPn3O-8xapsz</recordid><startdate>20150604</startdate><enddate>20150604</enddate><creator>Padhi, Smita</creator><creator>Glen, Jessica</creator><creator>Pordes, Ben A J</creator><creator>Thomas, Mark E</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150604</creationdate><title>Management of anaemia in chronic kidney disease: summary of updated NICE guidance</title><author>Padhi, Smita ; Glen, Jessica ; Pordes, Ben A J ; Thomas, Mark E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b312t-ac776b08b0ecc28378abe0e6dcb673b53c1c5a55ae74812bfe16a7862f1e76d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anemia</topic><topic>Anemia - complications</topic><topic>Anemia - diagnosis</topic><topic>Anemia - therapy</topic><topic>Blood diseases</topic><topic>Cohort analysis</topic><topic>Cost analysis</topic><topic>GUIDELINES</topic><topic>Hemodialysis</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Investigations</topic><topic>Iron</topic><topic>Kidney diseases</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - diagnosis</topic><topic>Renal Insufficiency, Chronic - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Padhi, Smita</creatorcontrib><creatorcontrib>Glen, Jessica</creatorcontrib><creatorcontrib>Pordes, Ben A J</creatorcontrib><creatorcontrib>Thomas, Mark E</creatorcontrib><creatorcontrib>Guideline Development Group</creatorcontrib><creatorcontrib>on behalf of the Guideline Development Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Padhi, Smita</au><au>Glen, Jessica</au><au>Pordes, Ben A J</au><au>Thomas, Mark E</au><aucorp>Guideline Development Group</aucorp><aucorp>on behalf of the Guideline Development Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of anaemia in chronic kidney disease: summary of updated NICE guidance</atitle><jtitle>BMJ (Online)</jtitle><addtitle>BMJ</addtitle><date>2015-06-04</date><risdate>2015</risdate><volume>350</volume><issue>jun04 6</issue><spage>h2258</spage><epage>h2258</epage><pages>h2258-h2258</pages><issn>0959-8138</issn><issn>1756-1833</issn><eissn>1756-1833</eissn><abstract>About 5% of the population of the United States and United Kingdom have stages 3-5 chronic kidney disease (CKD; estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2),1 2 and about 15% of these people have anaemia according to World Health Organization criteria.2 Overall more than 100?000 people in the UK have anaemia of CKD.3 Anaemia of CKD develops as renal disease progresses, and it is mainly caused by erythropoietin deficiency; other contributory factors include deficiency of iron, folate, or vitamin B12; blood loss; and infection or inflammation. This article summarises 2006 and 2011 guidance from the National Institute for Health and Care Excellence (NICE) on the management of anaemia of CKD,3 4 and it also highlights key points of the 2015 update.5</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>26044132</pmid><doi>10.1136/bmj.h2258</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8138 |
| ispartof | BMJ (Online), 2015-06, Vol.350 (jun04 6), p.h2258-h2258 |
| issn | 0959-8138 1756-1833 1756-1833 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1702644443 |
| source | Jstor Complete Legacy; MEDLINE; BMJ Journals - NESLi2 |
| subjects | Anemia Anemia - complications Anemia - diagnosis Anemia - therapy Blood diseases Cohort analysis Cost analysis GUIDELINES Hemodialysis Hemoglobin Humans Investigations Iron Kidney diseases Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - diagnosis Renal Insufficiency, Chronic - therapy |
| title | Management of anaemia in chronic kidney disease: summary of updated NICE guidance |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T04%3A13%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20anaemia%20in%20chronic%20kidney%20disease:%20summary%20of%20updated%20NICE%20guidance&rft.jtitle=BMJ%20(Online)&rft.au=Padhi,%20Smita&rft.aucorp=Guideline%20Development%20Group&rft.date=2015-06-04&rft.volume=350&rft.issue=jun04%206&rft.spage=h2258&rft.epage=h2258&rft.pages=h2258-h2258&rft.issn=0959-8138&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.h2258&rft_dat=%3Cjstor_proqu%3E26520870%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777760714&rft_id=info:pmid/26044132&rft_jstor_id=26520870&rfr_iscdi=true |